• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

A range of substances with antitumor properties was synthesized at RUDN University

Bioengineer by Bioengineer
October 13, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Maria Matveeva

Scientists from RUDN University have synthesized a number of new cytotoxic substances – the ones that can damage cells. In the future the results of the study can be used in cancer therapy. The compounds were obtained by domino reaction, a successive formation of several new chemical bonds. The study was published in the Synthesis journal.

In search of a cure for cancer scientists are looking for new ways to synthesize compounds similar to natural alkaloids – organic substances of plant or marine origin containing a nitrogen atom. Alkaloids of the lamellarin group – the substances derived from Lamellaria mollusks – are known to have cytotoxic and immunomodulatory (immune-regulating) activity as well as anti-inflammatory properties. Lamellarin compounds are of great interest at the moment to scientists looking for a substance with high anticancer activity.

One of the methods for synthesizing new organic compounds is the domino reaction, a process in which several new bonds are formed successively, just like dominoes put in a row fall one after another if you push the last of them. The initial stage of synthesis is crucial. The first stage of the reaction is nucleophilic addition. During this reaction the molecule is affected by a nucleophilic (Latin for "core loving") reagent, or nucleophile. Such reagents generally include particles (anions or molecules) with an unshared electron pair at an external electronic level (as, for example, in OH-, Cl-, Br- and water molecules).

Scientists used the nucleophilic addition reaction for α, β-unsaturated compounds containing not only single carbon-carbon bonds, but also double ones. The carbon atoms in the chain are numbered with the letters of the Latin alphabet: this means that the in α, β-unsaturated compounds the second and the third carbon atoms have a double bond. This process is known as Michael's addition. Domino reactions involved 1-aroyl-3,4-dihydroisoquinolines and aldehydes with a multiple bond. As a result, there was a consecutive generation of several intermediate substances – the intermediates.

During the domino reaction RUDN University chemists were able to obtain a number of pyrrolo[2,1-α]isoquinolines with an aldehyde functional group in just one step. The resulting compounds showed cytotoxic activity in a number of tumor cells (lung carcinoma cells, intestinal carcinomas, cervical adenocarcinomas and sarcoma cells) during primary bioscreening. The bioscreening was carried out by scientists from the Institute of Physiologically Active Compounds (IPAC), RAS.

"The fragment of 5,6-dihydropyrrolo[2,1-α]isoquinoline is the core for such alkaloids as cryptaustoline and cryptowoline (derived from algae), as well as lamellarins," said one of the authors of the paper Maria Matveeva, a postgraduate student in the Department of Organic Chemistry at RUDN University. "Further research will be aimed at modifying the compounds obtained in order to increase their anticancer activity."

###

Media Contact

Valeriya V. Antonova
[email protected]

http://www.rudn.ru/en/

Related Journal Article

http://dx.doi.org/10.1055/s-0036-1588486

Share12Tweet8Share2ShareShareShare2

Related Posts

Succinate Receptor 1 Limits Blood Cell Formation, Leukemia

February 7, 2026

Palmitoylation of Tfr1 Drives Platelet Ferroptosis and Exacerbates Liver Damage in Heat Stroke

February 7, 2026

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Succinate Receptor 1 Limits Blood Cell Formation, Leukemia

Palmitoylation of Tfr1 Drives Platelet Ferroptosis and Exacerbates Liver Damage in Heat Stroke

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.